Table of Contents
ToggleDepending on the various sale patterns of different drugs, it is important to categorize different revenue generating segments in the product list of any PCD pharma company.
Profitable segments in PCD pharma are any lines of products where the company makes the most money. For example, a drug that is used to treat a health condition would be considered a top revenue generating segment.
Because certain drugs are more profitable than others, often there are several different revenue generating segments within a pharmaceutical company.
For example, there could be a top revenue generating segment for each drug family. Or, there could be one top revenue generating segment for all of the drugs that are sold in the same therapeutic area.
While some drugs have obvious appeal (like the ones used to treat diabetes), other drugs have very low sales because they have limited utility or have poor outcomes for patients.
In addition, some drugs generate high revenues because they have a patent life cycle, which means that the patents expire and competitors can sell generic versions of the product.
As we have seen that global economic trends tend to have a limited effect on pharma industry growth. Due to the necessity of pharmaceutical goods people will continue to require medical products irrespective of their income levels.
We are going to talk about an industry that shows and has shown different sales pattern all around the year.
Drug sales pattern depends on different seasons, new molecules trending, any blockbuster drug introduced or any pandemic; pharma products keep on trending in the market.
The market revenues also show an historic growth worldwide motivated by the increase in the drugs demand.
The success of many pharma product, many times, depends on their time of market entry with regard to seasonal peak sales. Product marketing massively accelerates the pace of their sales.
Accessibility of medicines is of increased importance in the long run. Top revenue generating profitable segments in PCD pharma which are considerable are-
There are many PCD Pharma Franchise companies who have managed to master seasonality, turning it from a problem into an opportunity.
These companies have managed to increase their sales and their profits by improving the on-shelf availability of seasonal products and reducing residual stocks when the season ends.
Seasonality is a straight-forward principle when it comes to pharma, since there are times of the year when there is higher demand for certain drugs.
For instance, the demand for medication against the common flu typically rises when the temperatures begin to fall. It might be straight-forward to think of seasonal patterns in this industry in winter due to higher demands.
Analgesics and pain-killers normally report 16-17% growth during the June-July period. Anti-malarial drugs are more in demand during rainy season.
Similarly cold and flu season begins in October, peaks in February and can end as late as May.
Pharma franchise company that markets cold and flu products see a potential rise in the sale of drug.
So, seasonal drugs category is one of important segments in PCD pharma company to focus. This segment includes-
The prevalence of lifestyle-related illnesses, for example, diabetes, hypertension, cardiac and chronic kidney diseases have gone up in the last one decade.
Rural areas are fast catching up with the urban areas on this trend. Obesity is also becoming common in rural India which adds to that the consumption of tobacco and alcohol.
Moreover, the age at which people are getting heart attacks has come down steadily with several young patients having undetected blood pressure and diabetes.
Consumption of cholesterol-lowering drugs had nearly quadrupled, use of antidepressant drugs doubled and consumption of antihypertensive and antidiabetic drugs nearly doubled.
It is the fifth-largest market of pharma drugs for treating metabolic disorders such as diabetes, diseases of the thyroid and pituitary glands. Hence, it is the fastest-growing segment of the global pharma market.
Since these drug therapies are fast-moving categories for which people are willing to pay, pharma marketing companies too have interest in coming up with newer molecules where money can be made. This segment includes drugs of category-
Covid-related therapies such as pain management, vitamins, anti-infectives showed higher growth in sales. Covid-19 has recently been found to trigger new or early onset of diabetes in many people.
With an already high burden of non-communicable diseases, the impact of Covid-19 and post-Covid complications on lung health, cardiac and respiratory systems is vital.
Gradually intake of vitamins, salicylic acids, aspirins and antibiotics have increased. So, there is also a boost in the nutritional supplements segment.
Against this, chronic therapies continued to report high growth with anti-diabetic (32.7%) and cardiac (21%) drugs. The other fast- growing segments are hormones (24%), derma (21.9%) and anti-malarial (20.8%).
Some big pharma companies long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbuster drugs works well.
Over the counter drugs are the non-prescribed drugs which are easily available on the counter. They are sold directly to the consumer.
All the above discussed different segments should be included in your product list according to the seasonal and geographical demand for a successful PCD pharma company.
What are the Requirements for PCD Pharma Franchise?